Penwest Begins Next Study In Development Of Nalbuphine ER

Sat, 20 Jan 2007 02:00 PM EST

... Penwest Pharmaceuticals Co. (Nasdaq: PPCO) today announced that it has begun a Phase I safety study on a nalbuphine hydrochloride extended release tablet formulation (Nalbuphine ER) that the Company is developing for the treatment of pain. [click link for full article] ...